{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:40:03Z","timestamp":1780540803328,"version":"3.54.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s13679-020-00388-9","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T03:47:48Z","timestamp":1591415268000},"page":"193-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Polycystic ovary Syndrome in Adolescents: Pitfalls in Diagnosis and Management"],"prefix":"10.1007","volume":"9","author":[{"given":"Eirini","family":"Kostopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-4312","authenticated-orcid":false,"given":"Panagiotis","family":"Anagnostis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia K.","family":"Bosdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bessie E.","family":"Spiliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,6]]},"reference":[{"issue":"1","key":"388_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28\u201338e25. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.09.024.","journal-title":"Fertil Steril"},{"key":"388_CR2","doi-asserted-by":"publisher","unstructured":"Fanelli F, Gambineri A, Mezzullo M, Vicennati V, Pelusi C, Pasquali R, et al. Revisiting hyper- and hypo-androgenism by tandem mass spectrometry. Rev Endocr Metab Disord. 2013;14(2):185\u2013205. https:\/\/doi.org\/10.1007\/s11154-013-9243-y.","DOI":"10.1007\/s11154-013-9243-y"},{"key":"388_CR3","doi-asserted-by":"publisher","unstructured":"Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014;171(4):P1\u201329. https:\/\/doi.org\/10.1530\/EJE-14-0253.","DOI":"10.1530\/EJE-14-0253"},{"issue":"12","key":"388_CR4","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565\u201392. https:\/\/doi.org\/10.1210\/jc.2013-2350.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"388_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015;36(5):487\u2013525. https:\/\/doi.org\/10.1210\/er.2015-1018.","journal-title":"Endocr Rev"},{"key":"388_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bpobgyn.2016.04.002","volume":"37","author":"H Zhao","year":"2016","unstructured":"Zhao H, Lv Y, Li L, Chen ZJ. Genetic Studies on Polycystic Ovary Syndrome. Best Pract Res Clin Obstet Gynaecol. 2016;37:56\u201365. https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.04.002.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"8","key":"388_CR7","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/humrep\/dei009","volume":"20","author":"T Sir-Petermann","year":"2005","unstructured":"Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburu B, Gazitua R, et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod. 2005;20(8):2122\u20136. https:\/\/doi.org\/10.1093\/humrep\/dei009.","journal-title":"Hum Reprod"},{"issue":"6","key":"388_CR8","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1542\/peds.2015-1430","volume":"136","author":"RL Rosenfield","year":"2015","unstructured":"Rosenfield RL. The diagnosis of polycystic ovary syndrome in adolescents. Pediatrics. 2015;136(6):1154\u201365. https:\/\/doi.org\/10.1542\/peds.2015-1430.","journal-title":"Pediatrics."},{"key":"388_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1196\/annals.1365.014","volume":"1092","author":"R Pasquali","year":"2006","unstructured":"Pasquali R, Gambineri A. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann N Y Acad Sci. 2006;1092:158\u201374. https:\/\/doi.org\/10.1196\/annals.1365.014.","journal-title":"Ann N Y Acad Sci"},{"key":"388_CR10","doi-asserted-by":"publisher","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237\u201345. https:\/\/doi.org\/10.1210\/jc.2006-0178.","DOI":"10.1210\/jc.2006-0178"},{"issue":"4","key":"388_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.21037\/tp.2017.09.11","volume":"6","author":"MK Kamboj","year":"2017","unstructured":"Kamboj MK, Bonny AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies. Transl Pediatr. 2017;6(4):248\u201355. https:\/\/doi.org\/10.21037\/tp.2017.09.11.","journal-title":"Transl Pediatr"},{"issue":"6171","key":"388_CR12","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1136\/bmj.1.6171.1109","volume":"1","author":"WJ Cunliffe","year":"1979","unstructured":"Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J. 1979;1(6171):1109\u201310. https:\/\/doi.org\/10.1136\/bmj.1.6171.1109.","journal-title":"Br Med J"},{"issue":"8","key":"388_CR13","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1373\/49.8.1250","volume":"49","author":"DA Herold","year":"2003","unstructured":"Herold DA, Fitzgerald RL. Immunoassays for testosterone in women: better than a guess? Clin Chem. 2003;49(8):1250\u20131. https:\/\/doi.org\/10.1373\/49.8.1250.","journal-title":"Clin Chem"},{"issue":"8","key":"388_CR14","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1373\/49.8.1381","volume":"49","author":"J Taieb","year":"2003","unstructured":"Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem. 2003;49(8):1381\u201395. https:\/\/doi.org\/10.1373\/49.8.1381.","journal-title":"Clin Chem"},{"issue":"1","key":"388_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137. https:\/\/doi.org\/10.1093\/humrep\/deh098.","journal-title":"Hum Reprod"},{"issue":"10","key":"388_CR16","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666\u201372. https:\/\/doi.org\/10.1210\/jcem.84.10.6079.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"388_CR17","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","volume":"83","author":"WY Chang","year":"2005","unstructured":"Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril. 2005;83(6):1717\u201323. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.01.096.","journal-title":"Fertil Steril"},{"issue":"4","key":"388_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jpag.2005.05.006","volume":"18","author":"AR Fernandes","year":"2005","unstructured":"Fernandes AR. de Sa Rosa e Silva AC, Romao GS, Pata MC, dos Reis RM. Insulin resistance in adolescents with menstrual irregularities. J Pediatr Adolesc Gynecol. 2005;18(4):269\u201374. https:\/\/doi.org\/10.1016\/j.jpag.2005.05.006.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"388_CR19","unstructured":"Zawadzki JKDA. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, et al., editors. Polycystic ovary syndrome 1992. Boston: Blackwell Scientific Publications. p. 377\u201384."},{"key":"388_CR20","unstructured":"Terry NL, Ryan ME. Polycystic Ovary Syndrome (PCOS). Bethesda, Md: National Institutes of Health Library. 2012. Available at: http:\/\/prevention.nih.gov\/workshops\/2012\/pcos\/docs\/PCOS_Bibliography.pdf. Accessed 27 Mar 2013."},{"key":"388_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1196\/annals.1429.005","volume":"1135","author":"SK Blank","year":"2008","unstructured":"Blank SK, Helm KD, McCartney CR, Marshall JC. Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci. 2008;1135:76\u201384. https:\/\/doi.org\/10.1196\/annals.1429.005.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"388_CR22","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1093\/humrep\/der223","volume":"26","author":"C Villarroel","year":"2011","unstructured":"Villarroel C, Merino PM, Lopez P, Eyzaguirre FC, Van Velzen A, Iniguez G, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone. Hum Reprod. 2011;26(10):2861\u20138. https:\/\/doi.org\/10.1093\/humrep\/der223.","journal-title":"Hum Reprod"},{"issue":"2","key":"388_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.fertnstert.2010.06.015","volume":"95","author":"E Codner","year":"2011","unstructured":"Codner E, Villarroel C, Eyzaguirre FC, Lopez P, Merino PM, Perez-Bravo F, et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril. 2011;95(2):702\u20136e1\u20132. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.06.015.","journal-title":"Fertil Steril"},{"issue":"1","key":"388_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12916-020-01516-x","volume":"18","author":"AS Pena","year":"2020","unstructured":"Pena AS, Witchel SF, Hoeger KM, Oberfield SE, Vogiatzi MG, Misso M, et al. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 2020;18(1):72. https:\/\/doi.org\/10.1186\/s12916-020-01516-x.","journal-title":"BMC Med"},{"key":"388_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000375530","volume":"83","author":"SF Witchel","year":"2015","unstructured":"Witchel SF, Oberfield S, Rosenfield RL, Codner E, Bonny A, Ibanez L, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015;83:376\u201389. https:\/\/doi.org\/10.1159\/000375530.","journal-title":"Horm Res Paediatr"},{"issue":"8","key":"388_CR26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.18502\/ijrm.v17i8.4818","volume":"17","author":"MSG Naz","year":"2019","unstructured":"\u2022 Naz MSG, Tehrani FR, Majd HA, Ahmadi F, Ozgoli G, Fakari FR, et al. The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis. Int J Reprod Biomed (Yazd). 2019;17(8):533\u201342. https:\/\/doi.org\/10.18502\/ijrm.v17i8.4818. This meta-analysis recorded a wide variation (3.4% to 11%) in the prevalence of PCOS in adolescents, depending on the diagnostic criteria used.","journal-title":"Int J Reprod Biomed (Yazd)"},{"issue":"3","key":"388_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/gye.15.3.170.177","volume":"15","author":"CK Avvad","year":"2001","unstructured":"Avvad CK, Holeuwerger R, Silva VC, Bordallo MA, Breitenbach MM. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence. Gynecol Endocrinol. 2001;15(3):170\u20137.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"388_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/03014468300006161","volume":"10","author":"J Gardner","year":"1983","unstructured":"Gardner J. Adolescent menstrual characteristics as predictors of gynaecological health. Ann Hum Biol. 1983;10(1):31\u201340. https:\/\/doi.org\/10.1080\/03014468300006161.","journal-title":"Ann Hum Biol"},{"issue":"2","key":"388_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/humrep\/deh079","volume":"19","author":"MH van Hooff","year":"2004","unstructured":"van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum Reprod. 2004;19(2):383\u201392. https:\/\/doi.org\/10.1093\/humrep\/deh079.","journal-title":"Hum Reprod"},{"issue":"3","key":"388_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jpag.2016.11.009","volume":"30","author":"S Maslyanskaya","year":"2017","unstructured":"Maslyanskaya S, Talib HJ, Northridge JL, Jacobs AM, Coble C, Coupey SM. Polycystic ovary syndrome: an under-recognized cause of abnormal uterine bleeding in adolescents admitted to a children\u2019s hospital. J Pediatr Adolesc Gynecol. 2017;30(3):349\u201355. https:\/\/doi.org\/10.1016\/j.jpag.2016.11.009.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"388_CR31","doi-asserted-by":"publisher","first-page":"201.e1","DOI":"10.1016\/j.ajog.2010.03.008","volume":"203","author":"E Carmina","year":"2010","unstructured":"Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010;203(3):201.e1\u20135. https:\/\/doi.org\/10.1016\/j.ajog.2010.03.008.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"388_CR32","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0015-0282(01)01701-0","volume":"75","author":"SM Slayden","year":"2001","unstructured":"Slayden SM, Moran C, Sams WM Jr, Boots LR, Azziz R. Hyperandrogenemia in patients presenting with acne. Fertil Steril. 2001;75(5):889\u201392. https:\/\/doi.org\/10.1016\/s0015-0282(01)01701-0.","journal-title":"Fertil Steril"},{"issue":"1","key":"388_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ogc.2008.12.004","volume":"36","author":"SM Pfeifer","year":"2009","unstructured":"Pfeifer SM, Kives S. Polycystic ovary syndrome in the adolescent. Obstet Gynecol Clin N Am. 2009;36(1):129\u201352. https:\/\/doi.org\/10.1016\/j.ogc.2008.12.004.","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"6","key":"388_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/humupd\/dmg044","volume":"9","author":"AH Balen","year":"2003","unstructured":"Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update. 2003;9(6):505\u201314. https:\/\/doi.org\/10.1093\/humupd\/dmg044.","journal-title":"Hum Reprod Update"},{"key":"388_CR35","doi-asserted-by":"publisher","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.06.035.","DOI":"10.1016\/j.fertnstert.2008.06.035"},{"issue":"8469\u201370","key":"388_CR36","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/s0140-6736(85)92552-8","volume":"2","author":"J Adams","year":"1985","unstructured":"Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet. 1985;2(8469\u201370):1375\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(85)92552-8.","journal-title":"Lancet."},{"key":"388_CR37","doi-asserted-by":"publisher","unstructured":"Venturoli S, Porcu E, Fabbri R, Pluchinotta V, Ruggeri S, Macrelli S, et al. Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence. Pediatr Res. 1995;38(6):974\u201380. https:\/\/doi.org\/10.1203\/00006450-199512000-00024.","DOI":"10.1203\/00006450-199512000-00024"},{"issue":"3","key":"388_CR38","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0015-0282(16)56160-3","volume":"60","author":"NA Bridges","year":"1993","unstructured":"Bridges NA, Cooke A, Healy MJ, Hindmarsh PC, Brook CG. Standards for ovarian volume in childhood and puberty. Fertil Steril. 1993;60(3):456\u201360.","journal-title":"Fertil Steril"},{"issue":"10","key":"388_CR39","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1210\/jc.2006-0835","volume":"91","author":"M Mortensen","year":"2006","unstructured":"Mortensen M, Rosenfield RL, Littlejohn E. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab. 2006;91(10):3786\u201390. https:\/\/doi.org\/10.1210\/jc.2006-0835.","journal-title":"J Clin Endocrinol Metab"},{"key":"388_CR40","doi-asserted-by":"publisher","unstructured":"Hart R, Doherty DA, Norman RJ, Franks S, Dickinson JE, Hickey M, et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril. 2010;94(3):1118\u201321. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.11.002.","DOI":"10.1016\/j.fertnstert.2009.11.002"},{"key":"388_CR41","doi-asserted-by":"publisher","unstructured":"Ibanez L, Lopez-Bermejo A, Callejo J, Torres A, Cabre S, Dunger D, et al. Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth. J Clin Endocrinol Metab. 2008;93(1):196\u20139. https:\/\/doi.org\/10.1210\/jc.2007-1800.","DOI":"10.1210\/jc.2007-1800"},{"issue":"1","key":"388_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0015-0282(00)00584-7","volume":"74","author":"MH van Hooff","year":"2000","unstructured":"van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. Fertil Steril. 2000;74(1):49\u201358. https:\/\/doi.org\/10.1016\/s0015-0282(00)00584-7.","journal-title":"Fertil Steril"},{"issue":"4","key":"388_CR43","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.fertnstert.2005.04.039","volume":"84","author":"RY Yoo","year":"2005","unstructured":"Yoo RY, Sirlin CB, Gottschalk M, Chang RJ. Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study. Fertil Steril. 2005;84(4):985\u201395. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.04.039.","journal-title":"Fertil Steril"},{"issue":"Suppl 3","key":"388_CR44","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1542\/peds.2013-0490B","volume":"131","author":"LF Eichenfield","year":"2013","unstructured":"Eichenfield LF, Krakowski AC, Piggott C, Del Rosso J, Baldwin H, Friedlander SF, et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013;131(Suppl 3):S163\u201386. https:\/\/doi.org\/10.1542\/peds.2013-0490B.","journal-title":"Pediatrics."},{"key":"388_CR45","doi-asserted-by":"publisher","unstructured":"Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(4):1105\u201320. https:\/\/doi.org\/10.1210\/jc.2007-2437.","DOI":"10.1210\/jc.2007-2437"},{"issue":"12","key":"388_CR46","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1210\/jc.2007-1549","volume":"92","author":"KE Salley","year":"2007","unstructured":"Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. J Clin Endocrinol Metab. 2007;92(12):4546\u201356. https:\/\/doi.org\/10.1210\/jc.2007-1549.","journal-title":"J Clin Endocrinol Metab"},{"key":"388_CR47","doi-asserted-by":"publisher","unstructured":"Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(9):4133\u201360. https:\/\/doi.org\/10.1210\/jc.2009-2631.","DOI":"10.1210\/jc.2009-2631"},{"issue":"5","key":"388_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/met.2010.0039","volume":"8","author":"AA Bremer","year":"2010","unstructured":"Bremer AA. Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord. 2010;8(5):375\u201394. https:\/\/doi.org\/10.1089\/met.2010.0039.","journal-title":"Metab Syndr Relat Disord"},{"issue":"3","key":"388_CR49","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ecl.2005.04.005","volume":"34","author":"C Buggs","year":"2005","unstructured":"Buggs C, Rosenfield RL. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin N Am. 2005;34(3):677\u2013705, x. https:\/\/doi.org\/10.1016\/j.ecl.2005.04.005.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"3","key":"388_CR50","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1210\/jc.2014-3886","volume":"100","author":"R Hart","year":"2015","unstructured":"Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage. J Clin Endocrinol Metab. 2015;100(3):911\u20139. https:\/\/doi.org\/10.1210\/jc.2014-3886.","journal-title":"J Clin Endocrinol Metab"},{"key":"388_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","volume":"86","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism. 2018;86:33\u201343. https:\/\/doi.org\/10.1016\/j.metabol.2017.09.016.","journal-title":"Metabolism."},{"issue":"4","key":"388_CR52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219\u201331. https:\/\/doi.org\/10.1038\/nrendo.2010.217.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"388_CR53","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1210\/jcem.84.1.5393","volume":"84","author":"RS Legro","year":"1999","unstructured":"Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84(1):165\u20139. https:\/\/doi.org\/10.1210\/jcem.84.1.5393.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"388_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/obe.2007.0019","volume":"3","author":"S Sam","year":"2007","unstructured":"Sam S. Obesity and polycystic ovary syndrome. Obes Manag. 2007;3(2):69\u201373. https:\/\/doi.org\/10.1089\/obe.2007.0019.","journal-title":"Obes Manag"},{"issue":"6","key":"388_CR55","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1210\/jcem.83.6.4886","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001\u20135. https:\/\/doi.org\/10.1210\/jcem.83.6.4886.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"388_CR56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1210\/jcem-72-1-83","volume":"72","author":"JE Nestler","year":"1991","unstructured":"Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72(1):83\u20139. https:\/\/doi.org\/10.1210\/jcem-72-1-83.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"388_CR57","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1203\/01.pdr.0000246097.73031.27","volume":"60","author":"TS Hannon","year":"2006","unstructured":"Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res. 2006;60(6):759\u201363. https:\/\/doi.org\/10.1203\/01.pdr.0000246097.73031.27.","journal-title":"Pediatr Res"},{"issue":"6","key":"388_CR58","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1530\/EJE-10-0205","volume":"162","author":"R Alemzadeh","year":"2010","unstructured":"Alemzadeh R, Kichler J, Calhoun M. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome. Eur J Endocrinol. 2010;162(6):1093\u20139. https:\/\/doi.org\/10.1530\/EJE-10-0205.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"388_CR59","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1210\/jc.2005-1666","volume":"91","author":"AD Coviello","year":"2006","unstructured":"Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006;91(2):492\u20137. https:\/\/doi.org\/10.1210\/jc.2005-1666.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"388_CR60","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/archpedi.157.8.821","volume":"157","author":"S Cook","year":"2003","unstructured":"Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157(8):821\u20137. https:\/\/doi.org\/10.1001\/archpedi.157.8.821.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"388_CR61","first-page":"45","volume":"4","author":"AH Roe","year":"2011","unstructured":"Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol. 2011;4(2):45\u201351.","journal-title":"Rev Obstet Gynecol"},{"issue":"8","key":"388_CR62","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/01443615.2017.1318840","volume":"37","author":"L Li","year":"2017","unstructured":"\u2022 Li L, Feng Q, Ye M, He Y, Yao A, Shi K. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis. J Obstet Gynaecol. 2017;37(8):1036\u201347. https:\/\/doi.org\/10.1080\/01443615.2017.1318840. This meta-analysis highlighted the importance of preventing\/treating obesity for the management of PCOS in adolescents.","journal-title":"J Obstet Gynaecol"},{"key":"388_CR63","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1749-6632.2010.05648.x","volume":"1205","author":"V Bruni","year":"2010","unstructured":"Bruni V, Dei M, Nannini S, Balzi D, Nuvolone D. Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci. 2010;1205:175\u201384. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05648.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"388_CR64","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jadohealth.2009.10.008","volume":"46","author":"A Fulghesu","year":"2010","unstructured":"Fulghesu A, Magnini R, Portoghese E, Angioni S, Minerba L, Melis GB. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome. J Adolesc Health. 2010;46(5):474\u201381. https:\/\/doi.org\/10.1016\/j.jadohealth.2009.10.008.","journal-title":"J Adolesc Health"},{"key":"388_CR65","doi-asserted-by":"publisher","unstructured":"Rossi B, Sukalich S, Droz J, Griffin A, Cook S, Blumkin A, et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(12):4780\u20136. https:\/\/doi.org\/10.1210\/jc.2008-1198.","DOI":"10.1210\/jc.2008-1198"},{"issue":"2","key":"388_CR66","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.fertnstert.2008.06.004","volume":"92","author":"F Fruzzetti","year":"2009","unstructured":"Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril. 2009;92(2):626\u201334. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.06.004.","journal-title":"Fertil Steril"},{"issue":"9","key":"388_CR67","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1210\/jc.2004-0463","volume":"89","author":"L Ibanez","year":"2004","unstructured":"Ibanez L, Valls C, Marcos MV, Ong K, Dunger DB, De Zegher F. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab. 2004;89(9):4331\u20137. https:\/\/doi.org\/10.1210\/jc.2004-0463.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"388_CR68","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/138945010790030992","volume":"11","author":"VG Athyros","year":"2010","unstructured":"Athyros VG, Tziomalos K, Karagiannis A, Anagnostis P, Mikhailidis DP. Should adipokines be considered in the choice of the treatment of obesity-related health problems? Curr Drug Targets. 2010;11(1):122\u201335. https:\/\/doi.org\/10.2174\/138945010790030992.","journal-title":"Curr Drug Targets"},{"issue":"6","key":"388_CR69","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jpag.2016.05.006","volume":"29","author":"C Kaczmarek","year":"2016","unstructured":"\u2022 Kaczmarek C, Haller DM, Yaron M. Health-related quality of kife in adolescents and young Adults with Polycystic Ovary Syndrome: A Systematic Review. J Pediatr Adolesc Gynecol. 2016;29(6):551\u20137. https:\/\/doi.org\/10.1016\/j.jpag.2016.05.006. This meta-analysis showed a significant impairment in the quality of life of adolescent girls with PCOS. Body weight and BMI mediated this association.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"388_CR70","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.metabol.2005.11.003","volume":"55","author":"CJ Glueck","year":"2006","unstructured":"Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, Stroop DM, Wang P. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism. 2006;55(4):508\u201314. https:\/\/doi.org\/10.1016\/j.metabol.2005.11.003.","journal-title":"Metabolism."},{"issue":"1","key":"388_CR71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/AOG.0b013e318202b0a4","volume":"117","author":"A Dokras","year":"2011","unstructured":"Dokras A, Clifton S, Futterweit W, Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol. 2011;117(1):145\u201352. https:\/\/doi.org\/10.1097\/AOG.0b013e318202b0a4.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"388_CR72","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.fertnstert.2011.10.022","volume":"97","author":"A Dokras","year":"2012","unstructured":"Dokras A, Clifton S, Futterweit W, Wild R. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2012;97(1):225\u201330 e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.10.022.","journal-title":"Fertil Steril"},{"issue":"2","key":"388_CR73","first-page":"136","volume":"31","author":"M Bernadett","year":"2016","unstructured":"Bernadett M, Szeman NA. Prevalence of eating disorders among women with polycystic ovary syndrome. Psychiatr Hung. 2016;31(2):136\u201345.","journal-title":"Psychiatr Hung"},{"issue":"11","key":"388_CR74","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3109\/09513590.2011.564686","volume":"27","author":"MK Toscani","year":"2011","unstructured":"Toscani MK, Mario FM, Radavelli-Bagatini S, Wiltgen D, Matos MC, Spritzer PM. Effect of high-protein or normal-protein diet on weight loss, body composition, hormone, and metabolic profile in southern Brazilian women with polycystic ovary syndrome: a randomized study. Gynecol Endocrinol. 2011;27(11):925\u201330. https:\/\/doi.org\/10.3109\/09513590.2011.564686.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"388_CR75","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/153537020422900504","volume":"229","author":"DJ Salmi","year":"2004","unstructured":"Salmi DJ, Zisser HC, Jovanovic L. Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med (Maywood). 2004;229(5):369\u201377. https:\/\/doi.org\/10.1177\/153537020422900504.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"388_CR76","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/14656566.2019.1701655","volume":"21","author":"A Vatopoulou","year":"2020","unstructured":"Vatopoulou A, Tziomalos K. Management of obesity in adolescents with polycystic ovary syndrome. Expert Opin Pharmacother. 2020;21(2):207\u201311. https:\/\/doi.org\/10.1080\/14656566.2019.1701655.","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"388_CR77","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1210\/jc.2011-1609","volume":"96","author":"N Lass","year":"2011","unstructured":"Lass N, Kleber M, Winkel K, Wunsch R, Reinehr T. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J Clin Endocrinol Metab. 2011;96(11):3533\u201340. https:\/\/doi.org\/10.1210\/jc.2011-1609.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"388_CR78","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jpag.2015.01.002","volume":"28","author":"TM Marzouk","year":"2015","unstructured":"Marzouk TM, Sayed Ahmed WA. Effect of Dietary Weight Loss on Menstrual Regularity in Obese Young Adult Women with Polycystic Ovary Syndrome. J Pediatr Adolesc Gynecol. 2015;28(6):457\u201361. https:\/\/doi.org\/10.1016\/j.jpag.2015.01.002.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"388_CR79","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/s0015-0282(02)02993-x","volume":"77","author":"G Mastorakos","year":"2002","unstructured":"Mastorakos G, Koliopoulos C, Creatsas G. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril. 2002;77(5):919\u201327. https:\/\/doi.org\/10.1016\/s0015-0282(02)02993-x.","journal-title":"Fertil Steril"},{"issue":"3","key":"388_CR80","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1210\/jc.2014-3196","volume":"100","author":"BO Yildiz","year":"2015","unstructured":"Yildiz BO. Approach to the patient: contraception in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100(3):794\u2013802. https:\/\/doi.org\/10.1210\/jc.2014-3196.","journal-title":"J Clin Endocrinol Metab"},{"key":"388_CR81","doi-asserted-by":"publisher","first-page":"CD003987","DOI":"10.1002\/14651858.CD003987.pub5","volume":"1","author":"MF Gallo","year":"2014","unstructured":"Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2014;1:CD003987. https:\/\/doi.org\/10.1002\/14651858.CD003987.pub5.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"388_CR82","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12020-019-01860-w","volume":"64","author":"A Wang","year":"2019","unstructured":"Wang A, Mo T, Li Q, Shen C, Liu M. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis. Endocrine. 2019;64(2):220\u201332. https:\/\/doi.org\/10.1007\/s12020-019-01860-w.","journal-title":"Endocrine."},{"issue":"2","key":"388_CR83","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/humupd\/dmx039","volume":"24","author":"M Luque-Ramirez","year":"2018","unstructured":"Luque-Ramirez M, Nattero-Chavez L, Ortiz Flores AE, Escobar-Morreale HF. Combined oral contraceptives and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018;24(2):225\u201341. https:\/\/doi.org\/10.1093\/humupd\/dmx039.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"388_CR84","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2265.2012.04466.x","volume":"78","author":"A Harmanci","year":"2013","unstructured":"Harmanci A, Cinar N, Bayraktar M, Yildiz BO. Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome. Clin Endocrinol. 2013;78(1):120\u20135. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04466.x.","journal-title":"Clin Endocrinol"},{"issue":"5","key":"388_CR85","doi-asserted-by":"publisher","first-page":"E902","DOI":"10.1210\/jc.2013-1041","volume":"98","author":"L Ibanez","year":"2013","unstructured":"Ibanez L, Diaz M, Sebastiani G, Marcos MV, Lopez-Bermejo A, de Zegher F. Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity. J Clin Endocrinol Metab. 2013;98(5):E902\u20137. https:\/\/doi.org\/10.1210\/jc.2013-1041.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"388_CR86","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/BF03346757","volume":"36","author":"R Pasquali","year":"2013","unstructured":"Pasquali R, Gambineri A. Glucose intolerance states in women with the polycystic ovary syndrome. J Endocrinol Investig. 2013;36(8):648\u201353. https:\/\/doi.org\/10.1007\/BF03346757.","journal-title":"J Endocrinol Investig"},{"issue":"8","key":"388_CR87","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1210\/jcem.86.8.7756","volume":"86","author":"L Ibanez","year":"2001","unstructured":"Ibanez L, Valls C, Ferrer A, Marcos MV, Rodriguez-Hierro F, de Zegher F. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism. J Clin Endocrinol Metab. 2001;86(8):3595\u20138. https:\/\/doi.org\/10.1210\/jcem.86.8.7756.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"388_CR88","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","volume":"87","author":"SA Arslanian","year":"2002","unstructured":"Arslanian SA, Lewy V, Danadian K, Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance. J Clin Endocrinol Metab. 2002;87(4):1555\u20139. https:\/\/doi.org\/10.1210\/jcem.87.4.8398.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"388_CR89","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1515\/jpem.2006.19.6.831","volume":"19","author":"CJ Glueck","year":"2006","unstructured":"Glueck CJ, Aregawi D, Winiarska M, Agloria M, Luo G, Sieve L, et al. Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2006;19(6):831\u201342. https:\/\/doi.org\/10.1515\/jpem.2006.19.6.831.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"388_CR90","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/s1054-139x(01)00202-6","volume":"29","author":"CJ Glueck","year":"2001","unstructured":"Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS). J Adolesc Health. 2001;29(3):160\u20139. https:\/\/doi.org\/10.1016\/s1054-139x(01)00202-6.","journal-title":"J Adolesc Health"},{"key":"388_CR91","doi-asserted-by":"publisher","unstructured":"Al Khalifah RA, Florez ID, Dennis B, Thabane L, Bassilious E. Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis. Pediatrics. 2016;137(5). https:\/\/doi.org\/10.1542\/peds.2015-4089.","DOI":"10.1542\/peds.2015-4089"},{"issue":"7\u20138","key":"388_CR92","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1515\/jpem-2014-0283","volume":"28","author":"H Al-Zubeidi","year":"2015","unstructured":"Al-Zubeidi H, Klein KO. Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome. J Pediatr Endocrinol Metab. 2015;28(7\u20138):853\u20138. https:\/\/doi.org\/10.1515\/jpem-2014-0283.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"388_CR93","doi-asserted-by":"publisher","unstructured":"Ganie MA, Khurana ML, Eunice M, Gupta N, Gulati M, Dwivedi SN, et al. Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study. J Clin Endocrinol Metab. 2004;89(6):2756\u201362. https:\/\/doi.org\/10.1210\/jc.2003-031780.","DOI":"10.1210\/jc.2003-031780"},{"key":"388_CR94","doi-asserted-by":"publisher","unstructured":"Zulian E, Sartorato P, Benedini S, Baro G, Armanini D, Mantero F, et al. Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile. J Endocrinol Investig. 2005;28(1):49\u201353. https:\/\/doi.org\/10.1007\/bf03345529.","DOI":"10.1007\/bf03345529"},{"issue":"5","key":"388_CR95","doi-asserted-by":"publisher","first-page":"bvaa032","DOI":"10.1210\/jendso\/bvaa032","volume":"4","author":"L Ibanez","year":"2020","unstructured":"Ibanez L, Diaz M, Garcia-Beltran C, Malpique R, Garde E, Lopez-Bermejo A, et al. Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome. J Endocr Soc. 2020;4(5):bvaa032. https:\/\/doi.org\/10.1210\/jendso\/bvaa032.","journal-title":"J Endocr Soc"},{"issue":"3","key":"388_CR96","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0303-7207(86)90132-2","volume":"44","author":"J Simard","year":"1986","unstructured":"Simard J, Luthy I, Guay J, Belanger A, Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol. 1986;44(3):261\u201370. https:\/\/doi.org\/10.1016\/0303-7207(86)90132-2.","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"388_CR97","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1210\/jcem.85.9.6814","volume":"85","author":"L Ibanez","year":"2000","unstructured":"Ibanez L, Potau N, Marcos MV, de Zegher F. Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide. J Clin Endocrinol Metab. 2000;85(9):3251\u20135. https:\/\/doi.org\/10.1210\/jcem.85.9.6814.","journal-title":"J Clin Endocrinol Metab"},{"key":"388_CR98","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1749-6632.1993.tb43875.x","volume":"687","author":"IM Golland","year":"1993","unstructured":"Golland IM, Elstein ME. Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome. Ann N Y Acad Sci. 1993;687:263\u201371. https:\/\/doi.org\/10.1111\/j.1749-6632.1993.tb43875.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"388_CR99","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/s0015-0282(00)01764-7","volume":"75","author":"Y Sahin","year":"2001","unstructured":"Sahin Y, Dilber S, Kelestimur F. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril. 2001;75(3):496\u2013500. https:\/\/doi.org\/10.1016\/s0015-0282(00)01764-7.","journal-title":"Fertil Steril"},{"issue":"7","key":"388_CR100","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/pds.896","volume":"13","author":"HE Seaman","year":"2004","unstructured":"Seaman HE, de Vries CS, Farmer RD. Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database. Pharmacoepidemiol Drug Saf. 2004;13(7):427\u201336. https:\/\/doi.org\/10.1002\/pds.896.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"388_CR101","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpag.2013.09.010","volume":"27","author":"MV Tartagni","year":"2014","unstructured":"Tartagni MV, Alrasheed H, Damiani GR, Montagnani M, De Salvia MA, De Pergola G, et al. Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study. J Pediatr Adolesc Gynecol. 2014;27(3):161\u20135. https:\/\/doi.org\/10.1016\/j.jpag.2013.09.010.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"388_CR102","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jaad.2006.09.025","volume":"57","author":"I Hamzavi","year":"2007","unstructured":"Hamzavi I, Tan E, Shapiro J, Lui H. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol. 2007;57(1):54\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2006.09.025.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"388_CR103","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1524-4725.2006.32282.x","volume":"32","author":"SR Smith","year":"2006","unstructured":"Smith SR, Piacquadio DJ, Beger B, Littler C. Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial. Dermatol Surg. 2006;32(10):1237\u201343. https:\/\/doi.org\/10.1111\/j.1524-4725.2006.32282.x.","journal-title":"Dermatol Surg"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-020-00388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-020-00388-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-020-00388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T23:33:25Z","timestamp":1622936005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-020-00388-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,6]]},"references-count":103,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1007\/s13679-020-00388-9","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,6]]},"assertion":[{"value":"6 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}